At the American Society of Radiation Oncology (ASTRO) annual meeting in Chicago on Oct. 25, the ACCURE authors are presenting the survival results of those earlier interventions. The new study shows that overall survival went up for all patients who completed recommended treatments. Previous differences in rates of survival between races were eliminated.